Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitored by MAINTRAC® is a predictor for relapse: A preliminary report

World Journal of Surgical Oncology

Volumn 3, Issue , 2005, Pages

  Rolle, Axel ^a   Günzel, Rainer ^a   Pachmann, Ulrich ^a   Willen, Babette ^a   Höffken, Klaus ^a   Pachmann, Katharina ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CELL COUNT; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMETRY; DISEASE COURSE; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; SQUAMOUS CELL CARCINOMA;

EID: 27444444117     PISSN: 14777819     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-3-18     Document Type: Article

References (22)

1. Wingo PA, Cardinez CJ, Landis SH, Greenlee RT, Ries LA, Anderson RN, Thun MJ: Long term trends in cancer mortality in the United States 1996-1998. Cancer 2003, 97:3133-3275.
2. Bray F, Tykczynski JE, Parkin DM: Going up or coming down? The changing phases of the lung cancer epidemic from 1966-1999 in the 15 European Union countries. Eur J Cancer 2004, 40:96-125.
3. Xie L, Ugnat AM, Morriss J, Scmenciw R, Mao Y: Histology related variation in the treatment and survival of patients with lung carcinoma in Canada. Lung Cancer 2003, 42:127-139.
4. Takita H, Pitoniak RF: Induction therapy for locoregional lung cancer using paclitaxel combination. A preliminary report. J Exp Clin Cancer Res 2000, 19:291-293.
5. Pantel K, von Knebel Doeberitz M, Izbicki JR, Riethmüller G: Disseminierte Tumourzellen: Diagnostik, prognostische Relevanz, Phänotypisierung und therapeutische Strategien. Chirurg 1997, 68:1241-1250.
6. Bessa X, Elizalde JI, Boix L, Pinol V, Lacy AM, Salo J, Pique JM, Castells A: Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer. Gastroenterology 2001, 120:1084-1092.
7. Pachmann K, Heiß P, Demel U, Tilz G: Detection and quantification of small numbers of circulating tumor cells in peripheral blood using Laser Scanning Cytometry (LSC®). Clin Chem Lab Med 2001, 39:811-817.
8. Pachmann K, Lychatz S, Oblonczek G, Willen B: Tumourzell-Analyse mit kombinierter Magnetanreicherung, Laser-Scanning Zytometrie und visueller Kontrolle. Laborwelt 2001, Nr. N:23-26.
9. Schlimok G, Funke I, Pantel K, Strobel F, Lindemann F, Witte J, Riethmüller G: Micrometastatic tumour cells in bone marrow' of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer 1991, 27:1461-1465.
10. Cote RJ, Beattie EJ, Chaiwun B, Sevi SR, Harry J, Chen SC, Sherrod AF, Groshen S, Taylor CR: Detection of occult bone marrow micrometastases in patients with operable lung carcinoma. Ann Surg 1995, 222:423-425.
11. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF: Circulating tumor cells, disease progression, and survival in metastatic breast cancer. New Engl J Med 2004, 351:781-791.
12. Racila E, Euhus D, Weiss AJ, Rao C, Mc Connell J, Terstappen LW, Uhr JW: Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 1998, 95:4589-4594.
13. Krag DN, Ashikaga T, Moss TS, Kusminsky RE, Feldman S, Carp NZ, Moffat FL Jr, Beitsch PD, Frazier TG, Gaskin TA, Shook JW, Harlow SP, Weaver DL: Breast cancer cells in the blood; a pilot study. The Breast J 1999, 5:354-358.
14. Jung R, Petersen K, Krugar W, Wolf M, Wagener C, Zander A, Neumaier M: Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes. Br J Cancer 1999, 81:870-873.
15. Suchy B, Austrup F, Driesel G, Eder C, Kusiak I, Uciechowski P, Grill HJ, Giesing M: Detection of mammaglobin expressing cells in blood of breast cancer patients. Cancer Lett 2000, 158:171-178.
16. Wong IH, Chan AT, Johnson PJ: Quantitative analysis of circulating tumor cells in peripheral blood of osteosarcoma patients using osteoblast specific messenger RNA markers: a pilot study. Clin Canc Res 2000, 6:2183-2188.
17. Martin J, Ginsberg RJ, Venkatrman ES, Bains MS, Downey RJ, Korst RJ, Kris MG, Rusch VW: Long-term results of combined-modality therapy in resectable non-small cell lung cancer. J Clin Oncol 2002, 120:1989-1995.
18. Schleiermacher G, Delattre O: Detection of micrometastases and circulating tumour cells using molecular biology techniques in solid tumors. Bull Cancer 2001, 88:561-570.
19. Mehes G, Luegmayr A, Ambros IM, Ladenstein R, Ambros PF: Combined automatic immunological and molecular cytogenetic analysis allows exact identification and quantification of tumor cells in the bone marrow. Clin Canc Res 2001, 7:1969-1975.
20. Ghosh S, Ahmed K, Hopkinson DN, Vaughan R: Pulmonary adenocarcinoma is associated with poor long-term survival after surgical resection. Effect of allogeneic blood transfusion. Cancer 2004, 101:2058-2066.
21. Boldrini L, Cacinai A, Sarnaritani E, Pistolesi F, Mussi A, Lucchi M, Angeletti CA, Basolo F, Fontanini G: Tumor necrosis factor alpha and transforming growth factor beta are significantly associated with better prognosis in non small cell lung carcinoma: putative relation with BCL-2 mediated neovascularization. Br J Cancer 2000, 83:480-486.
22. MacDonald IC, Groom AC, Chambers AF: Cancer spread and micrometastases development: quantitative approaches for in vivo models. Bioassays 2002, 24:885-893.